|
Market Closed -
London S.E.
16:35:26 11/03/2026 GMT
|
5-day change
|
1st Jan Change
|
|
14,484.00 GBX
|
-1.16%
|
 |
-3.00%
|
+5.03%
|
|
03-09 |
Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB…
|  | |
03-04 |
Vicore Pharma Holding AB Announces Executive Changes
|
CI
| |
03-04 |
NervGen Pharma Corp. Announces Executive Changes
|
CI
| |
03-02 |
Apellis Pharmaceuticals, Inc. Appoints Mikael Dolsten to Board of Directors, Effective March 1, 2026
|
CI
| |
02-24 |
AstraZeneca PLC Announces Directorate And Committee Changes, Effective April 9, 2026
|
CI
| |
02-24 |
AstraZeneca announces retirement of non-executive director Nazneen Rahman
|
RE
| |
02-23 |
Tectonic Therapeutic, Inc. Announces Board and Committees Changes
|
CI
| |
02-18 |
Gensight Biologics Announces Executive Changes
|
CI
| |
02-17 |
Camurus Appoints Jane Buus Laursen as Chief Corporate Development Officer, Effective March 23, 2026
|
CI
| |
02-13 |
NatWest results ahead of forecasts, ups dividend 51%
|
AN
| |
02-12 |
Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant
|
RE
| |
02-11 |
China charges former AstraZeneca regional head Leon Wang
|
RE
| |
02-10 |
Helus Pharma Appoints Michael Cola as Chief Executive Officer, Effective February 10, 2026
|
CI
| |
02-10 |
BP halts buybacks; AstraZeneca lifts annual earnings
|
AN
| |
02-09 |
Ocugen, Inc. Announces Executive Changes, Effective February 9, 2026
|
CI
| |
02-05 |
Intervacc AB Announces Chief Executive Officer Changes
|
CI
| |
02-03 |
Kyverna Therapeutics, Inc. Appoints Mayo Pujols as Chief Technology Officer, Effective February 9, 2026
|
CI
| |
02-02 |
Harrow, Inc. Promotes Patrick W. Sullivan as Chief Commercial Officer, Effective January 30, 2026
|
CI
| |
02-02 |
Global markets live: Walt Disney, Oracle, Tesla, Electrolux, Ford…
| | |
02-02 |
HighTide Therapeutics Appoints Chief Medical Officer
|
MT
| |
02-02 |
HighTide Therapeutics, Inc. Appoints Dr. Filip Surmont As Chief Medical Officer
|
CI
| |
01-30 |
Moderna, Inc. Announces Executive and Committee Changes, Effective March 2, 2026
|
CI
| |
01-30 |
Moderna CMO Jacqueline Miller to step down
|
RE
| |
01-30 |
Immunocore Holdings plc Announces Executive Changes
|
CI
| |
01-29 |
Definium Therapeutics Appoints Roger Adsett to Board of Directors, Effective from January 29, 2026
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
